GEP20032924B - Novel Furan Diarylmethylidene Derivatives, Method for Their Preparation and Pharmaceutical Composition - Google Patents
Novel Furan Diarylmethylidene Derivatives, Method for Their Preparation and Pharmaceutical CompositionInfo
- Publication number
- GEP20032924B GEP20032924B GEAP19974555A GEAP1997004555A GEP20032924B GE P20032924 B GEP20032924 B GE P20032924B GE AP19974555 A GEAP19974555 A GE AP19974555A GE AP1997004555 A GEAP1997004555 A GE AP1997004555A GE P20032924 B GEP20032924 B GE P20032924B
- Authority
- GE
- Georgia
- Prior art keywords
- pharmaceutical composition
- preparation
- diarylmethylidene
- derivatives
- furan
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/58—One oxygen atom, e.g. butenolide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
1. Technical Result Increase in effectiveness of anti-inflammatory and analgetic properties. 2. Essence Furan diarylmethylidene derivatives of formula (I) (values R1, R2, R3, R4, X1, X2, Y1, Y2, A and B are defined in the description), method for its production, pharmaceutical composition containing the same and its use as anti-inflammatory and analgetic medicaments are. 3. Field of Application Medicine.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9604236A FR2747123B1 (en) | 1996-04-04 | 1996-04-04 | NOVEL DIARYLMETHYLIDENE TETRAHYDROFURANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND THERAPEUTIC USES |
FR9607922A FR2747124B1 (en) | 1996-04-04 | 1996-06-26 | NOVEL FURANIC DIARYLMETHYLIDENE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES |
Publications (1)
Publication Number | Publication Date |
---|---|
GEP20032924B true GEP20032924B (en) | 2003-03-25 |
Family
ID=9490907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GEAP19974555A GEP20032924B (en) | 1996-04-04 | 1997-04-03 | Novel Furan Diarylmethylidene Derivatives, Method for Their Preparation and Pharmaceutical Composition |
Country Status (28)
Country | Link |
---|---|
EP (1) | EP0891345B1 (en) |
JP (1) | JP2000508638A (en) |
KR (1) | KR20000005146A (en) |
CN (1) | CN1215396A (en) |
AR (1) | AR006539A1 (en) |
AT (1) | ATE204268T1 (en) |
AU (1) | AU717146B2 (en) |
BG (1) | BG62808B1 (en) |
BR (1) | BR9708510A (en) |
CA (1) | CA2248949A1 (en) |
CZ (1) | CZ318898A3 (en) |
DE (1) | DE69706157T2 (en) |
DK (1) | DK0891345T3 (en) |
EE (1) | EE03687B1 (en) |
ES (1) | ES2162678T3 (en) |
FR (2) | FR2747123B1 (en) |
GE (1) | GEP20032924B (en) |
IL (1) | IL126105A (en) |
NO (1) | NO984624L (en) |
NZ (1) | NZ331672A (en) |
PL (1) | PL329213A1 (en) |
PT (1) | PT891345E (en) |
RU (1) | RU2189979C2 (en) |
SI (1) | SI0891345T1 (en) |
SK (1) | SK283292B6 (en) |
TW (1) | TW353660B (en) |
WO (1) | WO1997037984A1 (en) |
ZA (1) | ZA972894B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6180651B1 (en) * | 1996-04-04 | 2001-01-30 | Bristol-Myers Squibb | Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics |
JP2001518087A (en) * | 1997-04-02 | 2001-10-09 | メルク フロスト カナダ アンド カンパニー | Α-Methylene-γ-lactones as selective cyclooxygenase-2 inhibitors |
FR2775477B1 (en) * | 1998-02-27 | 2000-05-19 | Union Pharma Scient Appl | NOVEL HETEROCYCLIC DIARYLMETHYLENE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES |
CN1106392C (en) * | 2000-10-24 | 2003-04-23 | 中国科学院上海有机化学研究所 | Butenolide containing no substituent at beta position and its synthesis process |
EP1562930A4 (en) * | 2002-11-05 | 2008-12-10 | Magnachem Int Lab Inc | Synthetic lactone formulations and method of use |
ATE515493T1 (en) * | 2003-03-31 | 2011-07-15 | Council Scient Ind Res | MERCAPTOPHENYLNAPHTHYLMETHANE DERIVATIVES AND THEIR PRODUCTION |
PL1745791T3 (en) | 2003-05-07 | 2013-11-29 | Osteologix As | Treating cartilage/bone conditions with water-soluble strontium salts |
US8779168B2 (en) * | 2010-12-16 | 2014-07-15 | Transitions Optical, Inc. | Lactone compounds and materials made therefrom |
CA3209491A1 (en) | 2021-03-15 | 2022-09-22 | Saul Yedgar | Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0759432A1 (en) * | 1993-01-15 | 1997-02-26 | G.D. Searle & Co. | Use of medicaments containing 3,4-diaryl furans and analogs thereof for treating a skin-related condition |
US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
US5585504A (en) * | 1994-09-16 | 1996-12-17 | Merck & Co., Inc. | Process of making cox-2 inhibitors having a lactone bridge |
-
1996
- 1996-04-04 FR FR9604236A patent/FR2747123B1/en not_active Expired - Fee Related
- 1996-06-26 FR FR9607922A patent/FR2747124B1/en not_active Expired - Lifetime
-
1997
- 1997-03-24 TW TW086103701A patent/TW353660B/en active
- 1997-04-03 EE EE9800333A patent/EE03687B1/en unknown
- 1997-04-03 CA CA002248949A patent/CA2248949A1/en not_active Abandoned
- 1997-04-03 IL IL12610597A patent/IL126105A/en not_active IP Right Cessation
- 1997-04-03 RU RU98119887/04A patent/RU2189979C2/en not_active IP Right Cessation
- 1997-04-03 AU AU23933/97A patent/AU717146B2/en not_active Ceased
- 1997-04-03 CZ CZ983188A patent/CZ318898A3/en unknown
- 1997-04-03 BR BR9708510A patent/BR9708510A/en not_active IP Right Cessation
- 1997-04-03 JP JP9535910A patent/JP2000508638A/en active Pending
- 1997-04-03 DE DE69706157T patent/DE69706157T2/en not_active Expired - Lifetime
- 1997-04-03 WO PCT/FR1997/000602 patent/WO1997037984A1/en not_active Application Discontinuation
- 1997-04-03 ES ES97919476T patent/ES2162678T3/en not_active Expired - Lifetime
- 1997-04-03 EP EP97919476A patent/EP0891345B1/en not_active Expired - Lifetime
- 1997-04-03 CN CN97193543A patent/CN1215396A/en active Pending
- 1997-04-03 SK SK1375-98A patent/SK283292B6/en not_active IP Right Cessation
- 1997-04-03 PT PT97919476T patent/PT891345E/en unknown
- 1997-04-03 SI SI9730222T patent/SI0891345T1/en unknown
- 1997-04-03 DK DK97919476T patent/DK0891345T3/en active
- 1997-04-03 NZ NZ331672A patent/NZ331672A/en unknown
- 1997-04-03 GE GEAP19974555A patent/GEP20032924B/en unknown
- 1997-04-03 AT AT97919476T patent/ATE204268T1/en active
- 1997-04-03 KR KR1019980707808A patent/KR20000005146A/en not_active Application Discontinuation
- 1997-04-03 PL PL97329213A patent/PL329213A1/en unknown
- 1997-04-04 ZA ZA9702894A patent/ZA972894B/en unknown
- 1997-04-04 AR ARP970101359A patent/AR006539A1/en not_active Application Discontinuation
-
1998
- 1998-09-16 BG BG102771A patent/BG62808B1/en unknown
- 1998-10-02 NO NO984624A patent/NO984624L/en not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP9801169A0 (en) | N-hydroxy-B-sulfonyl propionamide derivatives. | |
IL123293A (en) | Piperidine derivatives, their preparation and pharmaceutical compositions containing them | |
GEP20032896B (en) | 4-Aminothiazole Derivatives, Containing Them Pharmaceutical Compositions Inhibiting Cyclin-Dependent Kinases and Methods for Treatment | |
MY115662A (en) | Novel compounds with analgesic effect | |
GEP20002210B (en) | Acridine Derivatives | |
GEP20043163B (en) | Inhibitors of Caspases, Pharmaceutical Composition on its Base and Method for its Production | |
YU57600A (en) | Bicyclic hydroxamic acid derivatives | |
GEP20032998B (en) | Substituted Benzenesulfonamide Derivatives as Prodrugs of Cox-2 Inhibitors | |
MY132705A (en) | Novel compounds with analgesic effect | |
GEP20053474B (en) | Glucocorticoid Receptor Modulators | |
AU4264396A (en) | Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof | |
AU649115B2 (en) | New heterocycle-substituted alkylamides, process for preparing them and pharmaceutical compositions containing them | |
ZA948669B (en) | New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions | |
IL94433A0 (en) | Aminophenol derivatives,their preparation and pharmaceutical compositions containing them | |
MY123193A (en) | Novel 2-(iminomethyl)amino-phenyl derivatives,preparation,application as medicines and compositions containing same | |
MX9804226A (en) | Novel 2,3,5-trimethyl-4-hydroxy anilide derivatives, preparation thereof and therapeutical use thereof. | |
EP0279149A3 (en) | Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same | |
AU656466B2 (en) | New benzimidazole compounds, a process for their preparation and pharmaceutical compositions containing them | |
GEP20032924B (en) | Novel Furan Diarylmethylidene Derivatives, Method for Their Preparation and Pharmaceutical Composition | |
GEP20043227B (en) | 5HT1 Antagonists for Antidepressant Therapy | |
NO960632D0 (en) | New bis-naphthalimides for the treatment of cancer | |
MY120550A (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions. | |
MY114282A (en) | Anthracycline derivatives | |
DE69837045D1 (en) | TRIPLE COMPOUNDS, METHOD FOR THE PRODUCTION AND INTERMEDIATE PRODUCTS OF THIS METHOD, THEIR APPLICATION AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
NZ515108A (en) | Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments |